What is the elephant in the room when considering new therapies for fungal diseases?

References

• Abzug MJ, Walsh TJ. 2004. Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children. Pediatr Infect Dis J. 23(8):769–773.
   PubMed Web of Science ®Google Scholar
• Ada G. 1991. Vaccine development. Real and imagined dangers. Nature. 349(6308):369.
   PubMed Web of Science ®Google Scholar
• Adenis AA, Valdes A, Cropet C, McCotter OZ, Derado G, Couppie P, Chiller T, Nacher M. 2018. Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study. Lancet Infect Dis. 18(10):1150–1159.
   PubMed Web of Science ®Google Scholar
• Ahmad SR, Singer SJ, Leissa BG. 2001. Congestive heart failure associated with itraconazole. Lancet. 357(9270):1766–1767.
   PubMed Web of Science ®Google Scholar
• Alqarihi A, Singh S, Edwards JE, Ibrahim AS, Uppuluri P. 2019. NDV-3A vaccination prevents C. albicans colonization of jugular vein catheters in mice. Sci Rep. 9(1):6194.
   PubMedGoogle Scholar
• Anderson M, Schulze K, Cassini A, Plachouras D, Mossialos E. 2019. A governance framework for development and assessment of national action plans on antimicrobial resistance. Lancet Infect Dis. 19(11):e371–e384.
   PubMed Web of Science ®Google Scholar
• Antachopoulos C, Katragkou A, Roilides E. 2012. Immunotherapy against invasive mold infections. Immunotherapy. 4(1):107–120.
   PubMed Web of Science ®Google Scholar
• Arendrup MC, Perlin DS. 2014. Echinocandin resistance: an emerging clinical problem? Curr Opin Infect Dis. 27(6):484–492.
   PubMed Web of Science ®Google Scholar
• Aykut B, Pushalkar S, Chen R, Li Q, Abengozar R, Kim JI, Shadaloey SA, Wu D, Preiss P, Verma N, et al. 2019. The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature. 574(7777):264–267.
   PubMed Web of Science ®Google Scholar
• Bar-On YM, Phillips R, Milo R. 2018. The biomass distribution on Earth. Proc Natl Acad Sci USA. 115(25):6506–6511.
   PubMed Web of Science ®Google Scholar
• Bebber DP. 2019. Climate change effects on Black Sigatoka disease of banana. Philos Trans R Soc Lond B Biol Sci. 374(1775):20180269.
   PubMed Web of Science ®Google Scholar
• Bernardo SM, Allen CP, Waller A, Young SM, Oprea T, Sklar LA, Lee SA. 2014. An automated high-throughput cell-based multiplexed flow cytometry assay to identify novel compounds to target Candida albicans virulence-related proteins. PLoS One. 9(10):e110354.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 441(7090):235–238.
   PubMed Web of Science ®Google Scholar
• Blankenship JR, Steinbach WJ, Perfect JR, Heitman J. 2003. Teaching old drugs new tricks: reincarnating immunosuppressants as antifungal drugs. Curr Opin Investig Drugs. 4(2):192–199.
   PubMedGoogle Scholar
• Bongomin F, Gago S, Oladele R, Denning D. 2017. Global and multi-national prevalence of fungal diseases-estimate precision. JoF. 3(4):57.
   Google Scholar
• Borges SRC, Sperandio da Silva GM, da Costa Chambela M, de Oliveira Rd-VC, Braga Costa RL, Wanke B, do Valle ACF. 2014. Itraconazole vs. trimethoprim-sulfamethoxazole: a comparative cohort study of 200 patients with paracoccidioidomycosis. Med Mycol. 52(3):303–310.
   PubMed Web of Science ®Google Scholar
• Boulware DR, Nalintya E, Rajasingham R, Kirumira P, Naluyima R, Turya F, Namanda S, Rutakingirwa MK, Skipper CP, Nikweri Y, et al. 2020. Adjunctive sertraline for asymptomatic cryptococcal antigenemia: a randomized clinical trial. Med Mycol. 58(8):1037–1043.
   PubMed Web of Science ®Google Scholar
• Brown EM, McTaggart LR, Dunn D, Pszczolko E, Tsui KG, Morris SK, Stephens D, Kus JV, Richardson SE. 2018. Epidemiology and geographic distribution of blastomycosis, histoplasmosis, and coccidioidomycosis, Ontario, Canada, 1990-2015. Emerg Infect Dis. 24(7):1257–1266.
   PubMed Web of Science ®Google Scholar
• Bugli F, Cacaci M, Martini C, Torelli R, Posteraro B, Sanguinetti M, Sterbini FP. 2013. Human monoclonal antibody-based therapy in the treatment of invasive candidiasis. Clin Dev Immunol. 2013:403121.
   PubMedGoogle Scholar
• Buil J, Rijs A, Meis J, Birch M, Law D, Melchers W, Verweij P. 2017. In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates. J Antimicrob Chemother. 72(9):2548–2552.
   PubMed Web of Science ®Google Scholar
• Buil JB, Hare RK, Zwaan BJ, Arendrup MC, Melchers WJG, Verweij PE. 2019. The fading boundaries between patient and environmental routes of triazole resistance selection in Aspergillus fumigatus. PLoS Pathog. 15(8):e1007858.
   PubMed Web of Science ®Google Scholar
• Butts A, DiDone L, Koselny K, Baxter BK, Chabrier-Rosello Y, Wellington M, Krysan DJ. 2013. A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of Cryptococcosis. Eukaryot Cell. 12(2):278–287.
   PubMedGoogle Scholar
• Butts A, Krysan DJ. 2012. Antifungal drug discovery: something old and something new. PLoS Pathog. 8(9):e1002870–11.
   Web of Science ®Google Scholar
• Campoy S, Adrio JL. 2017. Antifungals. Biochem Pharmacol. 133:86–96.
   PubMed Web of Science ®Google Scholar
• Cannon GJ, Swanson JA. 1992. The macrophage capacity for phagocytosis. J Cell Sci. 101(4):907–913.
   PubMedGoogle Scholar
• Casadevall A, Kontoyiannis DP, Robert V. 2019. On the emergence of Candida auris: climate change, azoles, swamps, and birds. MBio. 10(4):e01397–19.
   PubMed Web of Science ®Google Scholar
• Casadevall A, Pirofski LA. 2012. Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases. Cell Host Microbe. 11(5):447–456.
   PubMed Web of Science ®Google Scholar
• Cavalcante Rd-S, Sylvestre TF, Levorato AD, de Carvalho LR, Mendes RP. 2014. Comparison between itraconazole and cotrimoxazole in the treatment of paracoccidiodomycosis. PLoS Negl Trop Dis. 8(4):e2793.
   PubMed Web of Science ®Google Scholar
• Chadha S, Kale SP. 2015. Simple fluorescence-based high throughput cell viability assay for filamentous fungi. Lett Appl Microbiol. 61(3):238–244.
   PubMed Web of Science ®Google Scholar
• Cleary JD, Stover KR. 2015. Antifungal-associated drug-induced cardiac disease. Clin Infect Dis. 61(6):S662–S668.
   PubMedGoogle Scholar
• Cong L, Liao Y, Yang S, Yang R. 2016. In vitro antifungal activity of sertraline and synergistic effects in combination with antifungal drugs against planktonic forms and biofilms of clinical Trichosporon asahii isolates. PLoS One. 11(12):e0167903.
   PubMed Web of Science ®Google Scholar
• Couzin-Frankel J. 2016. Worries, confusion after cancer trial deaths. Science. 354(6317):1211.
   PubMed Web of Science ®Google Scholar
• Dale J, James A, Paul J-Y, Khanna H, Smith M, Peraza-Echeverria S, Garcia-Bastidas F, Kema G, Waterhouse P, Mengersen K, et al. 2017. Transgenic cavendish bananas with resistance to Fusarium wilt tropical race 4. Nat Commun. 8(1):1496.
   PubMedGoogle Scholar
• Dar OA, Hasan R, Schlundt J, Harbarth S, Caleo G, Dar FK, Littmann J, Rweyemamu M, Buckley EJ, Shahid M, et al. 2016. Exploring the evidence base for national and regional policy interventions to combat resistance. Lancet. 387(10015):285–295.
   PubMed Web of Science ®Google Scholar
• Dartevelle P, Ehlinger C, Zaet A, Boehler C, Rabineau M, Westermann B, Strub J-M, Cianferani S, Haïkel Y, Metz-Boutigue M-H, et al. 2018. D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infections. Sci Rep. 8(1):9235.
   PubMedGoogle Scholar
• De Oliveira HC, Monteiro MC, Rossi SA, Pemán J, Ruiz-Gaitán A, Mendes-Giannini MJS, Mellado E, Zaragoza O. 2019. Identification of off-patent compounds that present antifungal activity against the emerging fungal pathogen Candida auris. Front Cell Infect Microbiol. 9:10–83.
   PubMed Web of Science ®Google Scholar
• Delsing CE, Gresnigt MS, Leentjens J, Preijers F, Frager FA, Kox M, Monneret G, Venet F, Bleeker-Rovers CP, van de Veerdonk FL, et al. 2014. Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series. BMC Infect Dis. 14:166.
   PubMed Web of Science ®Google Scholar
• Dennehy KM, Ferwerda G, Faro-Trindade I, Pyz E, Willment JA, Taylor PR, Kerrigan A, Tsoni SV, Gordon S, Meyer-Wentrup F, et al. 2008. Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors. Eur J Immunol. 38(2):500–506.
   PubMed Web of Science ®Google Scholar
• Denning DW. 2017. Calling upon all public health mycologists: to accompany the country burden papers from 14 countries. Eur J Clin Microbiol Infect Dis. 36(6):923–924.
   PubMedGoogle Scholar
• Denning DW, Bromley MJ. 2015. Infectious disease. How to bolster the antifungal pipeline. Science. 347(6229):1414–1416.
   PubMed Web of Science ®Google Scholar
• Di Mambro T, Guerriero I, Aurisicchio L, Magnani M, Marra E. 2019. The yin and yang of current antifungal therapeutic strategies: how can we harness our natural defenses? Front Pharmacol. 10:80.
   PubMed Web of Science ®Google Scholar
• Didone L, Scrimale T, Baxter BK, Krysan DJ. 2010. A high-throughput assay of yeast cell lysis for drug discovery and genetic analysis. Nat Protoc. 5(6):1107–1114.
   PubMed Web of Science ®Google Scholar
• Edwards JE, Jr, Schwartz MM, Schmidt CS, Sobel JD, Nyirjesy P, Schodel F, Marchus E, Lizakowski M, DeMontigny EA, Hoeg J, et al. 2018. A fungal immunotherapeutic vaccine (NDV-3A) for treatment of recurrent vulvovaginal candidiasis-a phase 2 randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 66(12):1928–1936.
   PubMed Web of Science ®Google Scholar
• Erwig LP, Gow NAR. 2016. Interactions of fungal pathogens with phagocytes. Nat Rev Microbiol. 14(3):163–176.
   PubMed Web of Science ®Google Scholar
• Estrada C, Desai AG, Chirch LM, Suh H, Seidman R, Darras F, Nord EP. 2012. Invasive aspergillosis in a renal transplant recipient successfully treated with interferon-gamma. Case Rep Transplant. 2012:493758.
   PubMedGoogle Scholar
• Fedorova O, Jagdmann GE, Adams RL, Yuan L, Van Zandt MC, Pyle AM. 2018. Small molecules that target group II introns are potent antifungal agents. Nat Chem Biol. 14(12):1073–1078.
   PubMed Web of Science ®Google Scholar
• Fernandes CM, Dasilva D, Haranahalli K, McCarthy JB, Mallamo J, Ojima I, Del Poeta M. 2021. The future of antifungal drug therapy: novel compounds and targets. Antimicrob Agents Chemother. 65(2):e01719–20.
   PubMed Web of Science ®Google Scholar
• Fisher MC, Henk DA, Briggs CJ, Brownstein JS, Madoff LC, McCraw SL, Gurr SJ. 2012. Emerging fungal threats to animal, plant and ecosystem health. Nature. 484(7393):186–194.
   PubMed Web of Science ®Google Scholar
• Gaviria JM, van Burik JA, Dale DC, Root RK, Liles WC. 1999. Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens. J Infect Dis. 179(4):1038–1041.
   PubMed Web of Science ®Google Scholar
• Ghannoum MA, Rice LB. 1999. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev. 12(4):501–517.
   PubMed Web of Science ®Google Scholar
• Ghini R, Bettiol W, Hamada E. 2011. Diseases in tropical and plantation crops as affected by climate changes: current knowledge and perspectives. Plant Pathol. 60(1):122–132.
   Web of Science ®Google Scholar
• Góralska K, Blaszkowska J, Dzikowiec M. 2018. Neuroinfections caused by fungi. Infection. 46(4):443–459.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Tomas E. 2003. New antifungal agents. Dermatol Clin. 21(3):565–576.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Versteeg SG. 2016. Tavaborole - a treatment for onychomycosis of the toenails. Expert Rev Clin Pharmacol. 9(9):1145–1152.
   PubMed Web of Science ®Google Scholar
• Hawksworth DL. 1991. The fungal dimension of biodiversity: magnitude, significance, and conservation. Mycol Res. 95(6):641–655.
   Google Scholar
• Hof H. 2008. Is there a serious risk of resistance development to azoles among fungi due to the widespread use and long-term application of azole antifungals in medicine? Drug Resist Updat. 11(1–2):25–31.
   PubMed Web of Science ®Google Scholar
• Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. 2014. SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol. 14:43.
   PubMed Web of Science ®Google Scholar
• Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O’Garra A, Murphy KM. 1993. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science. 260(5107):547–549.
   PubMed Web of Science ®Google Scholar
• Iannitti RG, Carvalho A, Romani L. 2012. From memory to antifungal vaccine design. Trends Immunol. 33(9):467–474.
   PubMed Web of Science ®Google Scholar
• Ibrahim AS, Luo G, Gebremariam T, Lee H, Schmidt CS, Hennessey JP, Jr, French SW, Yeaman MR, Filler SG, Edwards JE, Jr. 2013. NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response. Vaccine. 31(47):5549–5556.
   PubMed Web of Science ®Google Scholar
• Joffe LS, Schneider R, Lopes W, Azevedo R, Staats CC, Kmetzsch L, Schrank A, Del Poeta M, Vainstein MH, Rodrigues ML. 2017. The anti-helminthic compound mebendazole has multiple antifungal effects against Cryptococcus neoformans. Front Microbiol. 8:535.
   PubMed Web of Science ®Google Scholar
• Joly S, Ma N, Sadler JJ, Soll DR, Cassel SL, Sutterwala FS. 2009. Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome. J Immunol. 183(6):3578–3581.
   PubMed Web of Science ®Google Scholar
• Karwa R, Wargo KA. 2009. Efungumab: a novel agent in the treatment of invasive candidiasis. Ann Pharmacother. 43(11):1818–1823.
   PubMed Web of Science ®Google Scholar
• Kerr KW, Henry TC, Miller KL. 2018. Is the priority review voucher program stimulating new drug development for tropical diseases? PLoS Negl Trop Dis. 12(8):e0006695.
   PubMed Web of Science ®Google Scholar
• Kullberg B-J, van de Veerdonk F, Netea MG. 2014. Immunotherapy: a potential adjunctive treatment for fungal infection. Curr Opin Infect Dis. 27(6):511–516.
   PubMed Web of Science ®Google Scholar
• Kumaresan PR, Manuri PR, Albert ND, Maiti S, Singh H, Mi T, Roszik J, Rabinovich B, Olivares S, Krishnamurthy J, et al. 2014. Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection. Proc Natl Acad Sci USA. 111(29):10660–10665.
   PubMed Web of Science ®Google Scholar
• Larsen RA, Pappas PG, Perfect J, Aberg JA, Casadevall A, Cloud GA, James R, Filler S, Dismukes WE. 2005. Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis. Antimicrob Agents Chemother. 49(3):952–958.
   PubMed Web of Science ®Google Scholar
• Larwood DJ. 2020. Nikkomycin Z-ready to meet the promise? JoF. 6(4):261.
   Google Scholar
• Levings MK, Roncarolo MG. 2005. Phenotypic and functional differences between human CD4 + CD25+ and type 1 regulatory T cells. Curr Top Microbiol Immunol. 293:303–326.
   PubMed Web of Science ®Google Scholar
• Levorato AD, Moris DV, Cavalcante R de S, Sylvestre TF, de Azevedo PZ, de Carvalho LR, Mendes RP. 2018. Evaluation of the hepatobiliary system in patients with paracoccidioidomycosis treated with cotrimoxazole or itraconazole. Med Mycol. 56(5):531–540.
   PubMed Web of Science ®Google Scholar
• Liles WC, Huang JE, van Burik JA, Bowden RA, Dale DC. 1997. Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens. J Infect Dis. 175(4):1012–1015.
   PubMed Web of Science ®Google Scholar
• Liu M, Clemons KV, Bigos M, Medovarska I, Brummer E, Stevens DA. 2011. Immune responses induced by heat killed Saccharomyces cerevisiae: a vaccine against fungal infection. Vaccine. 29(9):1745–1753.
   PubMed Web of Science ®Google Scholar
• Liu W, Yu W, Chan K, Yang C, Wauters J, Verweij PE. 2019. Aspergillosis related to severe influenza: a worldwide phenomenon? Clin Respir J. 13(8):540–542.
   PubMed Web of Science ®Google Scholar
• Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, Colombo AL, Calvo B, Cuomo CA, Desjardins CA, et al. 2017. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 64(2):134–140.
   PubMed Web of Science ®Google Scholar
• Lu RM, Hwang YH, Liu IJ, Lee CC, Tsai HZ, Li HJ, Wu HC. 2020. Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci. 27(1):1.
   PubMed Web of Science ®Google Scholar
• Mahlapuu M, Håkansson J, Ringstad L, Björn C. 2016. Antimicrobial peptides: an emerging category of therapeutic agents. Front Cell Infect Microbiol. 6:194.
   PubMed Web of Science ®Google Scholar
• Mailer RKW, Joly AL, Liu S, Elias S, Tegner J, Andersson J. 2015. IL-1β promotes Th17 differentiation by inducing alternative splicing of FOXP3. Sci Rep. 5:14674.
   PubMed Web of Science ®Google Scholar
• Matthews RC, Rigg G, Hodgetts S, Carter T, Chapman C, Gregory C, Illidge C, Burnie J. 2003. Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90. Antimicrob Agents Chemother. 47(7):2208–2216.
   PubMed Web of Science ®Google Scholar
• Miró-Canturri A, Ayerbe-Algaba R, Smani Y. 2019. Drug repurposing for the treatment of bacterial and fungal infections. Front Microbiol. 10:41.
   PubMed Web of Science ®Google Scholar
• Moragues MD, Omaetxebarria MJ, Elguezabal N, Sevilla MJ, Conti S, Polonelli L, Pontón J. 2003. A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities. Infect Immun. 71(9):5273–5279.
   PubMed Web of Science ®Google Scholar
• Nami S, Mohammadi R, Vakili M, Khezripour K, Mirzaei H, Morovati H. 2019. Fungal vaccines, mechanism of actions and immunology: a comprehensive review. Biomed Pharmacother. 109:333–344.
   PubMed Web of Science ®Google Scholar
• Netea MG, Gow NA, Munro CA, Bates S, Collins C, Ferwerda G, Hobson RP, Bertram G, Hughes HB, Jansen T, Jacobs L, et al. 2006. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest. 116(6):1642–1650.
   PubMed Web of Science ®Google Scholar
• Neumann-Haefelin C, Thimme R. 2013. Adaptive immune responses in hepatitis C virus infection. Curr Top Microbiol Immunol. 369:243–262.
   PubMed Web of Science ®Google Scholar
• Oliver JD, Sibley GEM, Beckmann N, Dobb KS, Slater MJ, McEntee L, Du Pré S, Livermore J, Bromley MJ, Wiederhold NP, et al. 2016. F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase. Proc Natl Acad Sci USA. 113(45):12809–12814.
   PubMed Web of Science ®Google Scholar
• Ordonez N, Seidl MF, Waalwijk C, Drenth A, Kilian A, Thomma BPHJ, Ploetz RC, Kema GHJ. 2015. Worse comes to worst: bananas and Panama disease-when plant and pathogen clones meet. PLoS Pathog. 11(11):e1005197.
   PubMed Web of Science ®Google Scholar
• Pappas PG. 2014. Antifungal clinical trials and guidelines: what we know and do not know. Cold Spring Harb Perspect Med. 4(11):a019745.
   PubMed Web of Science ®Google Scholar
• Paul V, Rawal H. 2017. Cardiotoxicity with Itraconazole. BMJ Case Rep. 2017:219376.
   Google Scholar
• Perfect JR, Pfaller MA, Ostrosky-Zeichner L, Kontoyiannis DP. 2011. Invasive mycoses: evolving challenges and opportunities in antifungal therapy (multimedia activity). Am J Med. 124(10):S2–S3.
   PubMedGoogle Scholar
• Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. 2017. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis. 17(12):e383–e392.
   PubMed Web of Science ®Google Scholar
• Perruccio K, Tosti A, Burchielli E, Topini F, Ruggeri L, Carotti A, Capanni M, Urbani E, Mancusi A, Aversa F, et al. 2005. Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood. 106(13):4397–4406.
   PubMed Web of Science ®Google Scholar
• Pierce CG, Uppuluri P, Tristan AR, Wormley FL, Mowat E, Ramage G, Lopez-Ribot JL. 2008. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc. 3(9):1494–1500.
   PubMed Web of Science ®Google Scholar
• Prasad V, Ho N. 2014. Why do we continue to adopt medical practices based on pathophysiology alone when we should be insisting on clinical trials? J Clin Epidemiol. 67(4):361–363.
   PubMed Web of Science ®Google Scholar
• Queiroz-Telles F, Fahal AH, Falci DR, Caceres DH, Chiller T, Pasqualotto AC. 2017. Neglected endemic mycoses. Lancet Infect Dis. 17(11):e367–e377.
   PubMed Web of Science ®Google Scholar
• Rabjohns JLA, Park Y, Dehdashti J, Henderson C, Zelazny A, Metallo SJ, Zheng W, Williamson PR. 2014. A high-throughput screening assay for fungicidal compounds against Cryptococcus neoformans. J Biomol Screen. 19(2):270–277.
   PubMedGoogle Scholar
• Rhein J, Huppler Hullsiek K, Tugume L, Nuwagira E, Mpoza E, Evans EE, Kiggundu R, Pastick KA, Ssebambulidde K, Akampurira A, et al. 2019. Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial. Lancet Infect Dis. 19(8):843–851.
   PubMed Web of Science ®Google Scholar
• Rivera J, Zaragoza O, Casadevall A. 2005. Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cells. Infect Immun. 73(2):1141–1150.
   PubMed Web of Science ®Google Scholar
• Romani L. 2011. Immunity to fungal infections. Nat Rev Immunol. 11(4):275–288.
   PubMed Web of Science ®Google Scholar
• Roemer T, Krysan DJ. 2014. Antifungal drug development: challenges, unmet clinical needs, and new approaches. Cold Spring Harb Perspect Med. 4(5):a019703.
   PubMed Web of Science ®Google Scholar
• Rushton J, Ferreira JP, Stärk KDC. 2014. Antimicrobial resistance: the use of antimicrobials in the livestock sector. Paris (France): OECD; p. 68.
   Google Scholar
• Rybak JM, Ge W, Wiederhold NP, Parker JE, Kelly SL, Rogers PD, Fortwendel JR. 2019. Mutations in hmg1, challenging the paradigm of clinical triazole resistance in Aspergillus fumigatus. MBio. 10(2):e00437-19.
   PubMed Web of Science ®Google Scholar
• Sanguinetti M, Posteraro B, Beigelman-Aubry C, Lamoth F, Dunet V, Slavin M, Richardson MD. 2019. Diagnosis and treatment of invasive fungal infections: looking ahead. J Antimicrob Chemother. 74(2):ii27–ii37.
   PubMedGoogle Scholar
• Santos LA, Grisolia JC, Malaquias LCC, Paula FBA, Dias ALT, Burger E. 2020. Medication association and immunomodulation: an approach in fungal diseases and in particular in the treatment of paracoccidioidomycosis. Acta Trop. 206:105412.
   PubMed Web of Science ®Google Scholar
• Scheele BC, Pasmans F, Skerratt LF, Berger L, Martel A, Beukema W, Acevedo AA, Burrowes PA, Carvalho T, Catenazzi A, et al. 2019. Amphibian fungal panzootic causes catastrophic and ongoing loss of biodiversity. Science. 363(6434):1459–1463.
   PubMed Web of Science ®Google Scholar
• Seif M, Einsele H, Löffler J. 2019. CAR T cells beyond cancer: hope for immunomodulatory therapy of infectious diseases. Front Immunol. 10:2711.
   PubMed Web of Science ®Google Scholar
• Shapiro S, Beenhouwer DO, Feldmesser M, Taborda C, Carroll MC, Casadevall A, Scharff MD. 2002. Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3. Infect Immun. 70(5):2598–2604.
   PubMed Web of Science ®Google Scholar
• Shaw KJ, Schell WA, Covel J, Duboc G, Giamberardino C, Kapoor M, Moloney M, Soltow QA, Tenor JL, Toffaletti DL, et al. 2018. In vitro and in vivo evaluation of APX001A/APX001 and other Gwt1 inhibitors against Cryptococcus. Antimicrob Agents Chemother. 62(8):e00523–18.
   PubMed Web of Science ®Google Scholar
• Shi L, Albuquerque PC, Lazar-Molnar E, Wang X, Santambrogio L, Gácser A, Nosanchuk JD. 2008. A monoclonal antibody to Histoplasma capsulatum alters the intracellular fate of the fungus in murine macrophages. Eukaryot Cell. 7(7):1109–1117.
   PubMedGoogle Scholar
• Shields RK, Nguyen MH, Clancy CJ. 2015. Clinical perspectives on echinocandin resistance among Candida species. Curr Opin Infect Dis. 28:514–522.
   PubMed Web of Science ®Google Scholar
• Singh S, Uppuluri P, Mamouei Z, Alqarihi A, Elhassan H, French S, Lockhart SR, Chiller T, Edwards JE, Ibrahim AS. 2019. The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection. PLoS Pathog. 15(8):e1007460.
   PubMed Web of Science ®Google Scholar
• Slørdal L, Spigset O. 2006. Heart failure induced by non-cardiac drugs. Drug Saf. 29(7):567–586.
   PubMed Web of Science ®Google Scholar
• Snelders E, Camps SMT, Karawajczyk A, Schaftenaar G, Kema GHJ, van der Lee HA, Klaassen CH, Melchers WJG, Verweij PE. 2012. Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus. PLoS One. 7(3):e31801.
   PubMed Web of Science ®Google Scholar
• Speakman EA, Dambuza IM, Salazar F, Brown GD. 2020. T Cell Antifungal Immunity and the Role of C-Type Lectin Receptors. Trends Immunol. 41(1):61–76.
   PubMed Web of Science ®Google Scholar
• Spitzer M, Griffiths E, Blakely KM, Wildenhain J, Ejim L, Rossi L, De Pascale G, Curak J, Brown E, Tyers M, et al. 2011. Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole. Mol Syst Biol. 7(1):499.
   PubMedGoogle Scholar
• Stevens DA, Clemons KV, Liu A. 2011. Developing a vaccine against aspergillosis. Med Mycol. 49(S1):S170–S176.
   PubMedGoogle Scholar
• Stokstad E. 2019. Devastating banana disease may have reached Latin America, could drive up global prices. Science. DOI:10.1126/science.aay7681.
   Google Scholar
• Subramaniam K, Metzger B, Hanau LH, Guh A, Rucker L, Badri S, Pirofski LA. 2009. IgM(+) memory B cell expression predicts HIV-associated cryptococcosis status. J Infect Dis. 200(2):244–251.
   PubMed Web of Science ®Google Scholar
• Szymański P, Markowicz M, Mikiciuk-Olasik E. 2012. Adaptation of high-throughput screening in drug discovery-toxicological screening tests. Int J Mol Sci. 13(1):427–452.
   PubMed Web of Science ®Google Scholar
• Talhinhas P, Batista D, Diniz I, Vieira A, Silva DN, Loureiro A, Tavares S, Pereira AP, Azinheira HG, Guerra-Guimarães L, et al. 2017. The coffee leaf rust pathogen Hemileia vastatrix: one and a half centuries around the tropics. Mol Plant Pathol. 18(8):1039–1051.
   PubMed Web of Science ®Google Scholar
• Tang KL, Caffrey NP, Nóbrega DB, Cork SC, Ronksley PE, Barkema HW, Polachek AJ, Ganshorn H, Sharma N, Kellner JD, et al. 2017. Restricting the use of antibiotics in food-producing animals and its associations with antibiotic resistance in food-producing animals and human beings: a systematic review and meta-analysis. Lancet Planet Heal. 1(8):e316–e327.
   PubMedGoogle Scholar
• Thanner S, Drissner D, Walsh F. 2016. Antimicrobial resistance in agriculture. MBio. 7(2):e02227.
   PubMed Web of Science ®Google Scholar
• Thomas MA, He J, Peterson FC, Huppler AR, Volkman BF. 2018. The solution structure of CCL28 reveals structural lability that does not constrain antifungal activity. J Mol Biol. 430(18):3266–3282.
   PubMed Web of Science ®Google Scholar
• Tibayrenc M, Gladieux P, Byrnes EJ, Aguileta G, Fisher M, Billmyre RB, Heitman J, Giraud T. 2017. Epidemiology and evolution of fungal pathogens in plants and animals. In Tibayrenc M, editor. Genetics and evolution of infectious diseases. Amsterdam (The Nethwerlands): Elsevier; p. 59–132.
   Google Scholar
• Treviño-Rangel Rd-J, Villanueva-Lozano H, Hernández-Rodríguez P, Martínez-Reséndez MF, García-Juárez J, Rodríguez-Rocha H, González GM. 2016. Activity of sertraline against Cryptococcus neoformans: in vitro and in vivo assays. Med Mycol. 54(3):280–286.
   PubMed Web of Science ®Google Scholar
• Tudela JLR, Denning DW. 2017. Recovery from serious fungal infections should be realisable for everyone. Lancet Infect Dis. 17(11):1111–1113.
   PubMed Web of Science ®Google Scholar
• Vallabhaneni S, Chiller TM. 2016. Fungal infections and new biologic therapies. Curr Rheumatol Rep. 18(5):29.
   PubMed Web of Science ®Google Scholar
• van der Graaf CA, Netea MG, Verschueren I, van der Meer JW, Kullberg BJ. 2005. Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae. Infect Immun. 73(11):7458–7464.
   PubMed Web of Science ®Google Scholar
• Verweij PE, Snelders E, Kema GHJ, Mellado E, Melchers WJG. 2009. Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? Lancet Infect Dis. 9(12):789–795.
   PubMed Web of Science ®Google Scholar
• Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, et al. 2012. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 380(9859):2163–2196.
   PubMed Web of Science ®Google Scholar
• Wagener J, Malireddi RK, Lenardon MD, Köberle M, Vautier S, MacCallum DM, Biedermann T, Schaller M, Netea MG, Kanneganti TD, et al. 2014. Fungal chitin dampens inflammation through IL-10 induction mediated by NOD2 and TLR9 activation. PLoS Pathog. 10(4):e1004050.
   PubMed Web of Science ®Google Scholar
• Wall G, Chaturvedi AK, Wormley FL, Wiederhold NP, Patterson HP, Patterson TF, Lopez-Ribot JL. 2018. Screening a repurposing library for inhibitors of multidrug-resistant Candida auris identifies ebselen as a repositionable candidate for antifungal drug development. Antimicrob Agents Chemother. 62(10):e01084–18.
   PubMed Web of Science ®Google Scholar
• WHO. 2016. WHO Executive Board recommends mycetoma resolution to World Health Assembly. Geneva (Switzerland): World health organization.
   Google Scholar
• Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, Conley ME, Cunningham-Rundles C, Ochs HD. 2006. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine. 85(4):193–202.
   PubMed Web of Science ®Google Scholar
• Wong CH, Siah KW, Lo AW. 2019. Estimation of clinical trial success rates and related parameters. Biostatistics. 20(2):273–286.
   PubMed Web of Science ®Google Scholar
• Xander P, Vigna AF, Feitosa LDS, Pugliese L, Bailão AM, Soares C. M d A, Mortara RA, Mariano M, Lopes JD. 2007. A surface 75-kDa protein with acid phosphatase activity recognized by monoclonal antibodies that inhibit Paracoccidioides brasiliensis growth. Microbes Infect. 9(12–13):1484–1492.
   PubMed Web of Science ®Google Scholar
• Yamashita K, Miyazaki T, Fukuda Y, Mitsuyama J, Saijo T, Shimamura S, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, et al. 2019. The novel arylamidine T-2307 selectively disrupts yeast mitochondrial function by inhibiting respiratory chain complexes. Antimicrob Agents Chemother. 63(8):e00374-19.
   PubMed Web of Science ®Google Scholar
• Zhai B, Zhou H, Yang L, Zhang J, Jung K, Giam CZ, Xiang X, Lin X. 2010. Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect. J Antimicrob Chemother. 65(5):931–938.
   PubMed Web of Science ®Google Scholar
• Zhang J, van den Heuvel J, Debets AJM, Verweij PE, Melchers WJG, Zwaan BJ, Schoustra SE. 2017. Evolution of cross-resistance to medical triazoles in Aspergillus fumigatus through selection pressure of environmental fungicides. Proc R Soc B. 284(1863):20170635.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yan K, Zhang Y, Huang R, Bian J, Zheng C, Sun H, Chen Z, Sun N, An R, et al. 2007. High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proc Natl Acad Sci USA. 104(11):4606–4611.
   PubMed Web of Science ®Google Scholar
• Zijlstra EE, van de Sande WWJ, Welsh O, Mahgoub ES, Heikh Goodfellow M, Fahal AH. 2016. Mycetoma: a unique neglected tropical disease. Lancet Infect Dis. 16(1):100–112.
   PubMed Web of Science ®Google Scholar